Advertisement
U.S. markets closed

Royalty Pharma plc (RPRX)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Visitors trend2W10W9M
26.43+0.03 (+0.11%)
At close: 04:00PM EST
26.42 -0.01 (-0.04%)
After hours: 06:02PM EST
Full screen
Trade prices are not sourced from all markets
Previous Close26.40
Open26.38
Bid26.39 x 700
Ask26.45 x 600
Day's Range26.33 - 26.63
52 Week Range25.10 - 31.66
Volume2,377,504
Avg. Volume2,321,993
Market Cap15.572B
Beta (5Y Monthly)0.47
PE Ratio (TTM)10.41
EPS (TTM)2.54
Earnings DateFeb 13, 2025 - Feb 17, 2025
Forward Dividend & Yield0.84 (3.18%)
Ex-Dividend DateNov 15, 2024
1y Target Est41.53
  • GlobeNewswire

    Royalty Pharma Announces Inaugural Prize for Impact in Healthcare

    Royalty Pharma inaugural Prize for Impact in Healthcare awarded to Michael Milken, the founder of the Milken Institute, Faster Cures & the Prostate Cancer FoundationThe Prize includes a charitable donation to further fund medical researchNEW YORK, Nov. 14, 2024 (GLOBE NEWSWIRE) -- Royalty Pharma plc (Nasdaq: RPRX) today announced the inaugural Royalty Pharma Prize for Impact in Healthcare, which honors individuals or organizations who positively impact healthcare, was awarded to Michael Milken.

  • Simply Wall St.

    Royalty Pharma's (NASDAQ:RPRX) Profits May Not Reveal Underlying Issues

    The market shrugged off Royalty Pharma plc's ( NASDAQ:RPRX ) solid earnings report. We think that investors might be...